What is Medisolv?
Medisolv is recognized as a leading provider of healthcare quality data management solutions. Its comprehensive quality management platform, ENCOR, empowers healthcare organizations to streamline core measure abstraction, facilitate electronic measure capture across hospital and ambulatory settings, and aggregate data from diverse sources. The platform supports submission to various reporting entities, including CMS, TJC, other payers, state agencies, and organizations like ACOs. ENCOR is certified for all ambulatory and hospital electronic clinical quality measures (eCQMs) as part of the 2015 Cures Edition, and Medisolv itself is a CMS-approved MIPS Qualified Clinical Data Registry (QCDR) for 2022, highlighting its critical role in regulatory compliance and quality improvement within the healthcare sector.
How much funding has Medisolv raised?
Medisolv has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Medisolv
PPP
Public-Private Partnership
What's next for Medisolv?
The recent major strategic investment into Medisolv signals a pivotal growth phase for the company, likely aimed at expanding its market reach and enhancing its technological capabilities. Given the enterprise-level funding context, Medisolv is positioned for significant scaling, potentially focusing on further integration of its ENCOR platform into broader healthcare ecosystems and solidifying its position as a key player in healthcare data analytics and quality reporting. This capital infusion is expected to fuel innovation and strengthen its competitive advantage in a rapidly evolving healthcare IT market.
See full Medisolv company page
